IGI Laboratories, Inc. To Present At 25th Annual Oppenheimer Healthcare Conference On December 11, 2014
BUENA, N.J., Dec. 10, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based specialty generic pharmaceutical company, will be presenting at the 25TH Annual Oppenheimer Healthcare Conference. The Conference will take place on December 10-11, 2014 at The Crowne Plaza Times Square in New York, New York.
Jason Grenfell-Gardner, CEO and President and Jenniffer Collins, Chief Financial Officer of IGI Laboratories, Inc. will present on Thursday December 11, 2014 at 10:20 a.m. ET.
The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.igilabs.com. A replay will be available for 90 days.
About IGI Laboratories, Inc.
IGI Laboratories is a specialty generic drug development and manufacturing company. Our mission is to be a leading player in the specialty generic prescription drug market.
Logo - http://photos.prnewswire.com/prnh/20130827/MM70487LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/igi-laboratories-to-present-at-25th-annual-oppenheimer-healthcare-conference-on-december-11-2014-300007261.html
SOURCE IGI Laboratories, Inc.